Letter by Klein regarding article, "Evaluation of dose-related effects of aspirin on platelet function: Results From the Aspirin-Induced Platelet Effect (ASPECT) Study"

Circulation

Volumn 117, Issue 4, 2008, Pages

  Klein, Petra Susanne ^a  

^a Universitetssykehuset Nord Norge   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; SIBRAFIBAN;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD VESSEL OCCLUSION; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; ISCHEMIC HEART DISEASE; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; AMBULATORY CARE; DOSE RESPONSE; NOTE; STATISTICS; THROMBOCYTE; TREATMENT REFUSAL;

AMBULATORY CARE; ASPIRIN; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; TREATMENT REFUSAL;

EID: 41049083539     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.728634     Document Type: Letter

References (4)

1. Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US. Evaluation of doserelated effects of aspirin on platelet function: Results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation. 2007;115: 3156-3164.
2. Gencheva E, Sloan M, Leurgans S, Raman R, Harris Y, Gorelick P; AAASPS Investigators. Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology. 2004;23:61-66.
3. Topol EJ, Easton D, Harrington RA, Amarenco P, Califf RM, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Granett J, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Sigmon K, Pieper K, Vallee M, Willerson JT; Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation 2003;108: 399-406.
4. Newby LK Bhapkar MV, White HD, Moliterno DJ, LaPointe NM, Kandzari DE, Verheugt FW, Kramer JM, Armstrong PW, Califf RM; SYMPHONY and 2nd SYMPHONY investigators. Aspirin use post-acute coronary syndromes: Intolerance, bleeding and discontinuation. J Thromb Thrombolysis. 2003;119-128.